CLINICAL_TRIALS
trial_result
· 2025-08-22
Clinical Trial Update: Effect of Benralizumab in Atopic Dermatitis [Phase 2]
Summary
Phase 2 clinical trial evaluating benralizumab for atopic dermatitis has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: McMaster University | Conditions: Dermatitis, Atopic, Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2025-08-22